Cantel Medical Announces Patrick Bernardi as Senior Vice President, Marketing & Brand Strategy
HuFriedyGroup SVP & CMO Appointed to Newly Created Role
Chicago, IL, January 26, 2021 – Cantel Medical Corp (NYSE: CMD) today announced that Patrick Bernardi, SVP & Chief Marketing Officer for HuFriedyGroup, has been promoted to the newly created role of Senior Vice President, Marketing & Brand Strategy. Mr. Bernardi will report to Seth Yellin, Executive Vice President & Chief Growth Officer.
In this role, Mr. Bernardi will maintain responsibility for HuFriedyGroup Marketing & Brand Management, while also taking on an expanded role with the Medical Division and Cantel Corporate Communications. In support of the Medical Division, Mr. Bernardi will be responsible for the development and execution of a global brand strategy, along with customer experiences that support it. He will also focus on organizing and depicting the greater corporate and divisional brand architecture to demonstrate the overall breadth of the Cantel portfolio and its value proposition. At a Corporate level, Mr. Bernardi will support key areas such as public relations, corporate responsibility, investor materials, and other deliverables.
Prior to being appointed to this new role, Mr. Bernardi served as the Global Chief Marketing Officer and Senior Vice President for HuFriedyGroup where he was responsible for directing and managing the global brand marketing function, including brand strategy, digital customer engagement, content marketing, distributor demand generation, public relations, CRM, and creative services. In this capacity, he focused on clarifying and amplifying the Hu-Friedy brand story, in addition to implementing contemporary marketing approaches designed to better align with the mobile and digital expectations of modern target audiences. Over the last year, Mr. Bernardi has led the strategy and launch of the new HuFriedyGroup brand, which successfully redefined and expanded the organization’s value proposition, following the acquisition by Cantel Medical, and in conjunction with integrating Cantel’s dental sub-brands.
About Cantel Medical
Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, instruments and instrument reprocessing workflow systems serving the dental industry, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.
For further information, visit www.cantelmedical.com.
About HuFriedyGroup
HuFriedyGroup, the dental division of Cantel Medical Corp. (NYSE: CMD), is the global leader in infection prevention, dental instrument manufacturing, and instrument reprocessing workflows, with over 200 years of collective experience in the dental industry. HuFriedyGroup helps dental professionals be the best in practice by providing a complete circle of protection in the dental suite, bringing world class products, services, education, and communities that result in superior clinician performance, superior clinical outcomes, and safety for clinicians and patients. Headquartered in Chicago, HuFriedyGroup products are distributed in more than 100 countries, and the dental division maintains offices in Germany, Italy, China, Singapore, and Japan.
